Lysosomal phospholipase A2: A novel player in host immunity to Mycobacterium tuberculosis

European Journal of Immunology

Volumn 44, Issue 8, 2014, Pages 2394-2404

  Schneider, Bianca E ^a,b   Behrends, Jochen ^a   Hagens, Kristine ^a   Harmel, Nadine ^a   Shayman, James A ^c   Schaible, Ulrich E ^a,b,d  

^a RESEARCH CENTER BORSTEL   (Germany)

^b LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^c UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^d German Centre for Infection Research TTU TB   (Germany)

Author keywords

Immunity; Macrophages; Phospholipase; T cells; Tuberculosis

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 17; LYSOSOMAL PHOSPHOLIPASE A2; MONOCYTE CHEMOTACTIC PROTEIN 1; NITRIC OXIDE; PHOSPHOLIPASE A2; PROSTAGLANDIN E2; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; CYTOKINE; PHOSPHOLIPASE;

ADAPTIVE IMMUNITY; ADOPTIVE TRANSFER; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL LOAD; BACTERIAL STRAIN; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RESPONSE; ENZYME DEFICIENCY; ENZYME DEGRADATION; HISTOPATHOLOGY; INNATE IMMUNITY; LUNG ALVEOLUS MACROPHAGE; LUNG TUBERCULOSIS; LYMPHOCYTE COUNT; LYMPHOCYTIC INFILTRATION; MOUSE; NONHUMAN; PERITONEUM MACROPHAGE; PHOSPHOLIPID METABOLISM; PRIORITY JOURNAL; PROTEIN EXPRESSION; SURVIVAL TIME; ANIMAL; C57BL MOUSE; ENZYMOLOGY; IMMUNITY; IMMUNOLOGY; INFLAMMATION; LUNG; LYMPH NODE; LYSOSOME; MACROPHAGE; MYCOBACTERIUM TUBERCULOSIS; T LYMPHOCYTE; TH1 CELL; TUBERCULOSIS;

IMMUNITY; MACROPHAGES; PHOSPHOLIPASE; T CELLS; TUBERCULOSIS;

ADAPTIVE IMMUNITY; ANIMALS; CYTOKINES; INFLAMMATION; LUNG; LYMPH NODES; LYSOSOMES; MACROPHAGES; MICE; MICE, INBRED C57BL; MYCOBACTERIUM TUBERCULOSIS; PHOSPHOLIPASES A2; T-LYMPHOCYTES; TH1 CELLS; TUBERCULOSIS, PULMONARY; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84906090389     PISSN: 00142980     EISSN: 15214141     Source Type: Journal    
DOI: 10.1002/eji.201344383     Document Type: Article

References (31)

1. Roberts, M. F., Phospholipases: structural and functional motifs for working at an interface. FASEB J. 1996. 10: 1159-1172.
2. Hurley, B. P. and McCormick, B. A., Multiple roles of phospholipase A2 during lung infection and inflammation. Infect. Immun. 2008. 76: 2259-2272.
3. Nevalainen, T. J., Graham, G. G. and Scott, K. F., Antibacterial actions of secreted phospholipases A2. Review. Biochim. Biophys. Acta 2008. 1781: 1-9.
4. Abe, A., Hiraoka, M., Wild, S., Wilcoxen, S. E., Paine, R., 3rd and Shayman, J. A., Lysosomal phospholipase A2 is selectively expressed in alveolar macrophages. J. Biol. Chem. 2004. 279: 42605-42611.
5. Shayman, J. A., Kelly, R., Kollmeyer, J., He, Y. and Abe, A., Group XV phospholipase A, a lysosomal phospholipase A. Prog. Lipid Res. 2011. 50: 1-13.
6. Hiraoka, M., Abe, A., Lu, Y., Yang, K., Han, X., Gross, R. W. and Shayman, J. A., Lysosomal phospholipase A2 and phospholipidosis. Mol. Cell. Biol. 2006. 26: 6139-6148.
7. Korbel, D. S., Schneider, B. E. and Schaible, U. E., Innate immunity in tuberculosis: myths and truth. Microbes. Infect. 2008. 10: 995-1004.
8. Wolf, A. J., Desvignes, L., Linas, B., Banaiee, N., Tamura, T., Takatsu, K. and Ernst, J. D., Initiation of the adaptive immune response to Mycobacterium tuberculosis depends on antigen production in the local lymph node, not the lungs. J. Exp. Med. 2008. 205: 105-115.
9. Urdahl, K. B., Shafiani, S. and Ernst, J. D., Initiation and regulation of T-cell responses in tuberculosis. Mucosal. Immunol. 2011. 4: 288-293.
10. Wu, C. Y., Wang, K., McDyer, J. F. and Seder, R. A., Prostaglandin E2 and dexamethasone inhibit IL-12 receptor expression and IL-12 responsiveness. J. Immunol. 1998. 161: 2723-2730.
11. + T cells inhibits acquisition of ability to produce IFN-gamma and IL-2, but not IL-4 and IL-5. J. Immunol. 1995. 155: 4604-4612.
12. van der Pouw Kraan, T. C., Boeije, L. C., Smeenk, R. J., Wijdenes, J. and Aarden, L. A., Prostaglandin-E2 is a potent inhibitor of human interleukin 12 production. J. Exp. Med. 1995. 181: 775-779.
13. Harris, S. G., Padilla, J., Koumas, L., Ray, D. and Phipps, R. P., Prostaglandins as modulators of immunity. Trends Immunol. 2002. 23: 144-150.
14. Paduraru, C., Bezbradica, J. S., Kunte, A., Kelly, R., Shayman, J. A., Veerapen, N., Cox, L. R. et al., Role for lysosomal phospholipase A2 in iNKT cell-mediated CD1d recognition. Proc. Natl. Acad. Sci. USA 2013. 110: 5097-5102.
15. Gadola, S. D., Silk, J. D., Jeans, A., Illarionov, P. A., Salio, M., Besra, G. S., Dwek, R. et al., Impaired selection of invariant natural killer T cells in diverse mouse models of glycosphingolipid lysosomal storage diseases. J. Exp. Med. 2006. 203: 2293-2303.
16. Arora, P., Foster, E. L. and Porcelli, S. A., CD1d and natural killer T cells in immunity to Mycobacterium tuberculosis. Adv. Exp. Med. Biol. 2013. 783: 199-223.
17. Ehlers, S. and Schaible, U. E., The granuloma in tuberculosis: dynamics of a host-pathogen collusion. Front. Immunol. 2012. 3: 411.
18. Kipnis, A., Basaraba, R. J., Orme, I. M. and Cooper, A. M., Role of chemokine ligand 2 in the protective response to early murine pulmonary tuberculosis. Immunology 2003. 109: 547-551.
19. Zhou, Z., Connell, M. C. and MacEwan, D. J., TNFR1-induced NF-kappaB, but not ERK, p38MAPK or JNK activation, mediates TNF-induced ICAM-1 and VCAM-1 expression on endothelial cells. Cell. Signal. 2007. 19: 1238-1248.
20. Roach, D. R., Bean, A. G., Demangel, C., France, M. P., Briscoe, H. and Britton, W. J., TNF regulates chemokine induction essential for cell recruitment, granuloma formation, and clearance of mycobacterial infection. J. Immunol. 2002. 168: 4620-4627.
21. Algood, H. M., Lin, P. L. and Flynn, J. L., Tumor necrosis factor and chemokine interactions in the formation and maintenance of granulomas in tuberculosis. Clin. Infect Dis. 2005. 41(Suppl 3): S189-S193.
22. Chackerian, A. A., Alt, J. M., Perera, T. V., Dascher, C. C. and Behar, S. M., Dissemination of Mycobacterium tuberculosis is influenced by host factors and precedes the initiation of T-cell immunity. Infect. Immun. 2002. 70: 4501-4509.
23. Flynn, J. L., Goldstein, M. M., Chan, J., Triebold, K. J., Pfeffer, K., Lowenstein, C. J., Schreiber, R. et al., Tumor necrosis factor-alpha is required in the protective immune response against Mycobacterium tuberculosis in mice. Immunity 1995. 2: 561-572.
24. Vesosky, B., Rottinghaus, E. K., Stromberg, P., Turner, J. and Beamer, G., CCL5 participates in early protection against Mycobacterium tuberculosis. J. Leukoc. Biol. 2010. 87: 1153-1165.
25. Saukkonen, J. J., Bazydlo, B., Thomas, M., Strieter, R. M., Keane, J. and Kornfeld, H., Beta-chemokines are induced by Mycobacterium tuberculosis and inhibit its growth. Infect. Immun. 2002. 70: 1684-1693.
26. Makino, Y., Cook, D. N., Smithies, O., Hwang, O. Y., Neilson, E. G., Turka, L. A., Sato, H. et al., Impaired T cell function in RANTES-deficient mice. Clin. Immunol. 2002. 102: 302-309.
27. Camargo, J. F., Quinones, M. P., Mummidi, S., Srinivas, S., Gaitan, A. A., Begum, K., Jimenez, F. et al., CCR5 expression levels influence NFAT translocation, IL-2 production, and subsequent signaling events during T lymphocyte activation. J. Immunol. 2009. 182: 171-182.
28. Molon, B., Gri, G., Bettella, M., Gomez-Mouton, C., Lanzavecchia, A., Martinez, A. C., Manes, S. and Viola, A., T cell costimulation by chemokine receptors. Nat. Immunol. 2005. 6: 465-471.
29. Tsenova, L., Mangaliso, B., Muller, G., Chen, Y., Freedman, V. H., Stirling, D. and Kaplan, G., Use of IMiD3, a thalidomide analog, as an adjunct to therapy for experimental tuberculous meningitis. Antimicrob. Agents Chemother. 2002. 46: 1887-1895.
30. Abe, A., Kelly, R., Kollmeyer, J., Hiraoka, M., Lu, Y. and Shayman, J. A., The secretion and uptake of lysosomal phospholipase A2 by alveolar macrophages. J. Immunol. 2008. 181: 7873-7881.
31. Bancroft, G. J., Collins, H. L., Sigola, L. B. and Cross, C. E., Modulation of murine macrophage behavior in vivo and in vitro. Methods Cell Biol. 1994. 45: 129-146.